Association for Behavior Analysis International

The Association for Behavior Analysis International® (ABAI) is a nonprofit membership organization with the mission to contribute to the well-being of society by developing, enhancing, and supporting the growth and vitality of the science of behavior analysis through research, education, and practice.


32nd Annual Convention; Atlanta, GA; 2006

Event Details

Previous Page


Special Event #154
2006 ABA Tutorial: Measuring and Modulating the Reinforcing Efficacy of Drugs
Sunday, May 28, 2006
11:00 AM–11:50 AM
Centennial Ballroom II
Area: BPH
Chair: John M. Roll (Washington State University, Friends Research Institute)
2006 ABA Tutorial: Measuring and Modulating the Reinforcing Efficacy of Drugs
Abstract: This presentation will define relative reinforcing efficacy and describe the importance of the concept to behavioral pharmacology. Various procedures for measuring reinforcing efficacy and the pros and cons of using these procedures will be discussed. Similarly methods for modulating reinforcing efficacy, including both pharmacological and behavioral, will be explored. The role of individual differences in determining reinforcing efficacy will also be examined. The presentation will also address the applied significance of modulating reinforcing efficacy. Examples with both human and non-human participants will be used to demonstrate various points throughout the presentation.
CHRIS-ELLYN JOHANSON (Wayne State University)
Dr. Chris-Ellyn Johanson’s primary interest during her early career was in determining the influence of a broad spectrum of behavioral and pharmacological variables on the relative reinforcing efficacy of drugs of abuse and the development of sensitive approaches for assessing abuse liability of psychoactive drugs in rhesus monkeys. While still continuing her animal research at the University of Chicago, she also developed a human psychopharmacology program investigating the reinforcing effects of psychomotor stimulants and benzodiazepines in normal humans. When Dr. Johanson moved to USUHS, human behavioral pharmacology became her primary interest. At the ARC, her research interests broadened to include the epidemiology of drug abuse and the development of paradigms that would foster a biobehavioral understanding of vulnerability to substance abuse. Dr. Johanson has published more than 150 scientific articles, including several important reviews of the behavioral pharmacology of cocaine. She was also the editor of Drug and Alcohol Dependence from 1986 to 1998.



Back to Top
Modifed by Eddie Soh